Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For TRIP
Valuation Weak
14%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
33%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -25.29 1.69 2.27
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -1129.03 -31.75 -2.58
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -5.58 5.96 6.31
Cash 9.40 8.46 7.73
Capex 0.32 -0.12 -0.12
Free Cash Flow 250.32 0.89 -0.25
Revenue 0.96 2.85 2.83
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 1.44 0.86 0.84
Operating Margin -60.51 -0.04 0.09
ROA 70.84 -0.02 0.01
ROE 94.66 -0.07 0.04
ROIC -81.48 -0.03 0.17
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of TRIP is permitted for members.
5 Growth
The "Growth Entry" for the Focus of TRIP is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of TRIP is permitted for members.